These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 25355768)
1. Performance of Etest and disk diffusion for detection of ciprofloxacin and levofloxacin resistance in Salmonella enterica. Deak E; Hindler JA; Skov R; Sjölund-Karlsson M; Sokovic A; Humphries RM J Clin Microbiol; 2015 Jan; 53(1):298-301. PubMed ID: 25355768 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of Surrogate Disk Tests for Detection of Ciprofloxacin and Levofloxacin Resistance in Clinical Isolates of Salmonella enterica. Deak E; Skov R; Hindler JA; Humphries RM J Clin Microbiol; 2015 Nov; 53(11):3405-10. PubMed ID: 26292293 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Ciprofloxacin and Levofloxacin Disk Diffusion and Etest Using the 2019 Humphries RM; Hindler JA; Shaffer K; Campeau SA J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30567744 [TBL] [Abstract][Full Text] [Related]
4. Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica. Skov R; Matuschek E; Sjölund-Karlsson M; Åhman J; Petersen A; Stegger M; Torpdahl M; Kahlmeter G J Clin Microbiol; 2015 Nov; 53(11):3411-7. PubMed ID: 26292292 [TBL] [Abstract][Full Text] [Related]
5. Fluoroquinolone susceptibility testing of Salmonella enterica: detection of acquired resistance and selection of zone diameter breakpoints for levofloxacin and ofloxacin. Sjölund-Karlsson M; Howie RL; Crump JA; Whichard JM J Clin Microbiol; 2014 Mar; 52(3):877-84. PubMed ID: 24391204 [TBL] [Abstract][Full Text] [Related]
6. The Emergence of Reduced Ciprofloxacin Susceptibility in Salmonella enterica Causing Bloodstream Infections in Rural Ghana. Eibach D; Al-Emran HM; Dekker DM; Krumkamp R; Adu-Sarkodie Y; Cruz Espinoza LM; Ehmen C; Boahen K; Heisig P; Im J; Jaeger A; von Kalckreuth V; Pak GD; Panzner U; Park SE; Reinhardt A; Sarpong N; Schütt-Gerowitt H; Wierzba TF; Marks F; May J Clin Infect Dis; 2016 Mar; 62 Suppl 1():S32-6. PubMed ID: 26933017 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of quinolones for use in detection of determinants of acquired quinolone resistance, including the new transmissible resistance mechanisms qnrA, qnrB, qnrS, and aac(6')Ib-cr, in Escherichia coli and Salmonella enterica and determinations of wild-type distributions. Cavaco LM; Aarestrup FM J Clin Microbiol; 2009 Sep; 47(9):2751-8. PubMed ID: 19571019 [TBL] [Abstract][Full Text] [Related]
8. Foreign travel and decreased ciprofloxacin susceptibility in Salmonella enterica infections. Al-Mashhadani M; Hewson R; Vivancos R; Keenan A; Beeching NJ; Wain J; Parry CM Emerg Infect Dis; 2011 Jan; 17(1):123-5. PubMed ID: 21192872 [TBL] [Abstract][Full Text] [Related]
9. Low-level resistance to ciprofloxacin in non-Typhi Salmonella enterica isolated from human gastroenteritis in Dakar, Senegal (2004--2006). Sire JM; Garin B; Macondo EA Int J Antimicrob Agents; 2008 Jun; 31(6):581-2. PubMed ID: 18329856 [No Abstract] [Full Text] [Related]
10. Ciprofloxacin-resistant Salmonella enterica serovar Kentucky in Canada. Mulvey MR; Boyd DA; Finley R; Fakharuddin K; Langner S; Allen V; Ang L; Bekal S; El Bailey S; Haldane D; Hoang L; Horsman G; Louis M; Robberts L; Wylie J Emerg Infect Dis; 2013 Jun; 19(6):999-1001. PubMed ID: 23735312 [TBL] [Abstract][Full Text] [Related]
12. Pefloxacin as a surrogate marker for quinolone susceptibility in Sharma P; Dahiya S; Kumari B; Balaji V; Sood S; Das BK; Kapil A Indian J Med Res; 2017 May; 145(5):687-692. PubMed ID: 28948961 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin. Misra R; Thakare R; Amrin N; Prasad KN; Chopra S; Dhole TN Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):472-9. PubMed ID: 27618918 [TBL] [Abstract][Full Text] [Related]